WPRIM Management System> DCMS> Chinese Journal of Lung Cancer> 2007> 10> 2

Volume: 10 Issue: 2

1. Clinical characteristics and prognosis analysis of pulmonary carcinosarcoma (a report of 48 cases). Page:148—151
2. A randomized study comparing topotecan plus cisplatin versus etoposide plus carboplatin for previously untreated small cell lung cancer. Page:144—147
3. Randomized clinical trial of paclitaxel plus cisplatin versus gemcitabine plus cisplatin in the treatment of patients with advanced non-small cell lung cancer. Page:141—143
4. Clinical and prognostic significance of serum MMP-9, endostatin and VEGF in patients with advanced non-small cell lung cancer. Page:138—140
5. Prognostic value of survivin and cyclooxygenase-2 expression in non-small cell lung cancer: a tissue microarray analysis. Page:133—137
6. Correlation of integrin β1 mRNA and integrin β3 mRNA expression with microvascular density and biological behaviour of squamous cell carcinoma of the lung. Page:128—132
7. Variation of mitochondrial DNA noncoding region in lung cancer cell lines. Page:124—127
8. Construction of antisense Slp2 gene and its effects on growth and proliferation of lung cancer cell lines. Page:120—123
9. Clinicopathological features of inflammatory myofibroblastic tumors of the lung. Page:116—119
10. Risk factor of brain metastasis in locally advanced non-small cell lung cancer after surgery. Page:111—115
11. Survival analysis of completely resected stage IIIB non-small cell lung cancer. Page:107—110
12. Retrospective analysis of screening results of lung cancer cases among occupational population at high risk of lung cancer. Page:102—106
13. Expression and clinicopathological significance of OPN and CD44v6 in lung cancer. Page:98—101
14. Construction, expression and purification of kinase suppressor of Ras, KSR. Page:93—97
15. Construction and identification of synchronous nitric oxide-amplified gene circuits controlled by radiation. Page:88—92
16. Expression of survivin and PCNA in lung cancer cells induced by Gejiu mineral powder. Page:83—87